A study on the sensitivity test of cancer cells to anticancer drugs.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D003470:Culture Media; D003520:Cyclophosphamide / Q000494:pharmacology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008113:Liver Neoplasms; D008297:Male; D051379:Mice; D008937:Mitomycins / Q000494:pharmacology*; D009374:Neoplasms, Experimental / Q000378:metabolism*; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D010088:Oxidoreductases / Q000378:metabolism*; D011166:Porphyrins / Q000494:pharmacology*; D051381:Rats; D012517:Sarcoma, Yoshida / Q000378:metabolism*; D014527:Uric Acid / Q000097:blood* / Q000652:urine*
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003470:Culture Media; D008937:Mitomycins; D009588:Nitrogen Mustard Compounds; D011166:Porphyrins; D014527:Uric Acid; D003520:Cyclophosphamide; D010088:Oxidoreductases